Kevin Vu

MD | Pain Management


 300 1st Ave, Boston
    Massachusetts, 02129-3109

 617-952-5000    Maps & Directions
Kevin Vu is a Boston, Massachusetts based physiatrist who is specialized in Pain Management (PM&R). Active license number of Kevin Vu as Pain Management (PM&R) is 1017839 in Massachusetts.

Kevin Vu provides a high level of care, either as a primary physician or consultant, for patients experiencing problems with acute, chronic or cancer pain in both hospital and ambulatory settings. Patient care needs may also be coordinated with other specialists.
Complete Profile:
Kevin Vu speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Specialization: Pain Management (PM&R)
Credentials: MD
Gender:Male
Practice Address:300 1st Ave, Boston,
Massachusetts, 02129-3109
Phone:617-952-5000
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1144857780
NPI Enumeration Date: 24 Mar, 2020
NPI Last Update On: 19 Feb, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Kevin Vu are as mentioned below.
License NumberSpecializationStateStatus
1017839Pain Management MassachusettsPrimary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 300 1st Ave,
Boston, Massachusetts
Zip: 02129-3109
Phone Number: --
Fax Number: --
Patients can reach Kevin Vu at 300 1st Ave, Boston, Massachusetts or can call to book an appointment on 617-952-5000. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 July, 2025.
Comments/ Reviews: